Synergistic Integration of Shiga Toxin Effector Polypeptides with Emerging Technologies

The inventive concept integrates Shiga toxin effector polypeptides with emerging technologies such as AI, IoT, blockchain, and new materials to create a new, more powerful system for site-specific conjugation, disease treatment, and personalized medicine.

The original patent disclosed cell-targeting molecules and/or components of cell-targeting molecules comprising site-specific amino acid residues for linking Shiga toxin effector polypeptides to binding regions. However, the original patent had limitations in terms of scalability, security, and precision. The new inventive concept addresses these limitations by integrating Shiga toxin effector polypeptides with emerging technologies to create a more efficient, secure, and precise system.

The new inventive concept comprises a blockchain-based secure data storage module for storing and managing polypeptide sequences, an AI-powered polypeptide design module for generating optimized polypeptide sequences, and a cell-targeting molecule generation module for generating cell-targeting molecules based on the optimized polypeptide sequences. The system can be integrated with IoT-enabled biosensors for real-time detection of extracellular target biomolecules. Additionally, the system can be used for personalized medicine by integrating the Shiga toxin effector polypeptide with an AI-powered diagnostic module and a blockchain-based secure data storage module.

The new inventive concept is novel and non-obvious compared to the original patent because it integrates Shiga toxin effector polypeptides with emerging technologies, providing a new and unexpected solution to the problem of site-specific conjugation and disease treatment. The use of blockchain, AI, and IoT technologies provides a new level of security, precision, and scalability that is not achievable with the original patent.

Alternative embodiments of the inventive concept could include the use of different blockchain platforms, AI algorithms, or IoT devices. The system could also be integrated with other emerging technologies such as quantum computing or nanotechnology. Additionally, the system could be used for other applications such as vaccine development or gene therapy.

The inventive concept has significant commercial potential in the fields of personalized medicine, disease treatment, and vaccine development. The system could be used by pharmaceutical companies, research institutions, and hospitals to develop new treatments and therapies. The market for the inventive concept is expected to grow significantly in the coming years as the demand for personalized medicine and precision healthcare increases.